Literature DB >> 19800053

The synthesis of chitosan-based silver nanoparticles and their antibacterial activity.

Dongwei Wei1, Wuyong Sun, Weiping Qian, Yongzhong Ye, Xiaoyuan Ma.   

Abstract

Chitosan-based silver nanoparticles were synthesized by reducing silver nitrate salts with nontoxic and biodegradable chitosan. The silver nanoparticles thus obtained showed highly potent antibacterial activity toward both Gram-positive and Gram-negative bacteria, comparable with the highly active precursor silver salts. Silver-impregnated chitosan films were formed from the starting materials composed of silver nitrate and chitosan via thermal treatment. Compared with pure chitosan films, chitosan films with silver showed both fast and long-lasting antibacterial effectiveness against Escherichia coli. The silver antibacterial materials prepared in our present system are promising candidates for a wide range of biomedical and general applications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19800053     DOI: 10.1016/j.carres.2009.09.001

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  63 in total

1.  Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus.

Authors:  Ashley N Brown; Kathryn Smith; Tova A Samuels; Jiangrui Lu; Sherine O Obare; Maria E Scott
Journal:  Appl Environ Microbiol       Date:  2012-01-27       Impact factor: 4.792

Review 2.  Nano-engineered delivery systems for cancer imaging and therapy: Recent advances, future direction and patent evaluation.

Authors:  Ghazal Nabil; Ketki Bhise; Samaresh Sau; Mohamed Atef; Hossny A El-Banna; Arun K Iyer
Journal:  Drug Discov Today       Date:  2018-08-16       Impact factor: 7.851

3.  Antimicrobial Activity of Chitosan Film Forming Solution Enriched with Essential Oils; an in Vitro Assay.

Authors:  Kana Jean Raphaël; Amir Meimandipour
Journal:  Iran J Biotechnol       Date:  2017-08-19       Impact factor: 1.671

Review 4.  Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications.

Authors:  Raziye Mohammadpour; Marina A Dobrovolskaia; Darwin L Cheney; Khaled F Greish; Hamidreza Ghandehari
Journal:  Adv Drug Deliv Rev       Date:  2019-07-08       Impact factor: 15.470

5.  Validity of silver, chitosan, and curcumin nanoparticles as anti-Giardia agents.

Authors:  D E Said; L M Elsamad; Y M Gohar
Journal:  Parasitol Res       Date:  2012-03-06       Impact factor: 2.289

6.  Dual effects of β-cyclodextrin-stabilised silver nanoparticles: enhanced biofilm inhibition and reduced cytotoxicity.

Authors:  Swarna Jaiswal; Kunal Bhattacharya; Patrick McHale; Brendan Duffy
Journal:  J Mater Sci Mater Med       Date:  2015-01-18       Impact factor: 3.896

7.  An innovative approach to treating dental decay in children. A new anti-caries agent.

Authors:  Andréa Gadelha Ribeiro Targino; Miguel Angel Pelagio Flores; Valdeci Elias dos Santos Junior; Fabiana de Godoy Bené Bezerra; Hilzeth de Luna Freire; André Galembeck; Aronita Rosenblatt
Journal:  J Mater Sci Mater Med       Date:  2014-05-13       Impact factor: 3.896

8.  Wound healing applications of sericin/chitosan-capped silver nanoparticles incorporated hydrogel.

Authors:  Jyoti Verma; Jovita Kanoujia; Poonam Parashar; Chandra Bhusan Tripathi; Shubhini A Saraf
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

Review 9.  Progress in antiretroviral drug delivery using nanotechnology.

Authors:  Rama Mallipeddi; Lisa Cencia Rohan
Journal:  Int J Nanomedicine       Date:  2010-08-09

Review 10.  A Review on Chitosan's Uses as Biomaterial: Tissue Engineering, Drug Delivery Systems and Cancer Treatment.

Authors:  Rayssa de Sousa Victor; Adillys Marcelo da Cunha Santos; Bianca Viana de Sousa; Gelmires de Araújo Neves; Lisiane Navarro de Lima Santana; Romualdo Rodrigues Menezes
Journal:  Materials (Basel)       Date:  2020-11-06       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.